Identification and management of dyslipidemic children

Area of Science:

• Pediatrics
• Cardiology
• Public Health

Background:

• Atherosclerotic cardiovascular disease (ASCVD) is a primary cause of mortality in Western nations.
• Dyslipidemia is a significant ASCVD risk factor, with the atherosclerotic process initiating in childhood.
• Children with dyslipidemia and other risk factors like hypertension or obesity are considered high-risk.

Purpose of the Study:

• To outline a selective screening strategy for identifying high-risk children (ages 2-10) with dyslipidemia.
• To detail the recommended diagnostic assessments for these children.
• To describe management approaches for lowering elevated low-density lipoprotein cholesterol (LDL-C) in pediatric populations.

Main Methods:

• Selective screening for children aged 2-10 with a family history of dyslipidemia or early cardiovascular events.
• Lipid biochemical analysis, including assessment of ApoB, ApoA-I, and their ratio.
• Utilizing age- and sex-specific percentile values for total cholesterol and LDL-C interpretation.

Main Results:

• High-risk children require screening for dyslipidemia and associated risk factors.
• Management begins with lifestyle modifications: physical activity and a Step II diet (low saturated fat and cholesterol).
• Non-pharmacologic agents (fibers, stanols, sterols) are considered if diet is insufficient.
• Pharmacologic therapy is reserved for children over eight with persistent LDL-C above the 95th percentile.

Conclusions:

• Early identification and management of childhood dyslipidemia are crucial for preventing premature cardiovascular events.
• A multi-step approach, starting with lifestyle changes and progressing to medications if needed, is effective.
• Screening and intervention in high-risk children can mitigate long-term cardiovascular risk.